A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptoms

Mostrar otras versiones (1)

BACKGROUND: Although the coronavirus disease 19 (COVID-19) pandemic has now impacted the world for over two years, the persistent secondary neuropsychiatric effects are still not fully understood. These “long COVID” symptoms, also referred to as post-acute sequelae of SARS-CoV-2 infection (PASC), ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Badran, Bashar W., Huffman, Sarah M., Dancy, Morgan, Austelle, Christopher W., Bikson, Marom, Kautz, Steven A., George, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402278/
https://www.ncbi.nlm.nih.gov/pubmed/36002874
http://dx.doi.org/10.1186/s42234-022-00094-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402278/
https://www.ncbi.nlm.nih.gov/pubmed/36002874
http://dx.doi.org/10.1186/s42234-022-00094-y

Ejemplares similares